Cancerous tumors cause disease in two ways: they grow and spread. But a new immune therapy approach may be able to target both problems simultaneously.
Your trillions-strong ecosystem of gut microbes, in addition to its many other responsibilities, operates as a homespun pharmaceutical factory.
Much of what we know about the immune system comes from experiments conducted on mice. But lab mice are not little human beings. The two species are separated by both physiology and lifestyles. Stanford immunologist Mark Davis is calling on his colleagues to shift their research focus to people.
Scientists find new potential drug targets for heart disease and diabetes, while shedding more light on the genetics of cholesterol, a new study has found.
As someone who had spent her career studying molecules on a computer screen, experiments involving people were a revelation and inspiration for Jane Tseng, PhD, …
Scientists have measured the human “exposome,” or the particulates, chemicals, and microbes that individually swarm us all, in unprecedented detail.
John Ioannidis reflects on the phenomenon of "hyper-publishing," where certain scientists are listed as authors on scores of papers a year.
A new Stanford-led study catalogs the prevalence and types of deception by volunteers in clinical trials and suggests ways for investigators to root it out.
Stanford Biodesign trainees have developed new medical devices and diagnostics that have been used to help care for more than 1.5 million patients so far.
Chris Cheng, an adjunct professor of surgery, recently spent six months as a Visiting Fellow at Oxford.
Adjunct Professor Caitlin O’Connell-Rodwell studies elephant vocalizations and vibrations to inform research on hearing, hearing loss and deafness.
Stanford researchers identify a new protein that can fully substitute for one of the key "Yamanaka factors" to reprogram adult stem cells.
Continuously monitoring blood sugar levels turns up new evidence to suggest that more people have sharp increases in their blood sugar than expected.
John Ioannidis recommends a change to the standards of nutrition research studies, suggesting that, as they stand, the results are fairly unreliable.
Testing the side effects of every drug combination is impractical, but Stanford researchers think they have a better way: artificial intelligence.
Stanford researchers are hosting an online competition featuring virtual athletes. Their goal: help people learn to walk and run after losing a limb.